Your session is about to expire
Itraconazole vs Clotrimazole
Introduction
For patients suffering from fungal infections, certain medications that inhibit the growth of fungi can help in managing symptoms and clearing up the infection. Itraconazole and Clotrimazole are two such drugs commonly used to treat various forms of fungal infections. They each work by interfering with the cell membranes of fungi, but they have different modes of action and uses.
Itraconazole is classified as a triazole antifungal medication which works by inhibiting a specific enzyme (cytochrome P-450) essential for fungal growth, thereby affecting the synthesis of ergosterol, an important component of fungal cell membrane. It's generally used systemically for more severe or persistent infections.
On the other hand, Clotrimazole is classified as an imidazole antifungal medication primarily affecting also ergosterol synthesis but it's mostly utilized topically for mild to moderate skin or mucosal surface-related infections like athlete’s foot, jock itch and yeast infections due to its local efficacy on these superficial layers.
Itraconazole vs Clotrimazole Side By Side
| Attribute | Sporanox | Lotrimin |
|---|---|---|
| Brand Name | Sporanox | Lotrimin |
| Contraindications | Should not be taken with certain heart disease medications like quinidine and dofetilide. | Allergic reactions to clotrimazole or any component of the formulation. |
| Cost | For brand name, around $600 for 30 capsules. Generic costs between $80 and $250 for 30 capsules. | Brand name averages about $10–$15 for a 15g tube. Generic ranges from under a dollar up to about five dollars per tube. |
| Generic Name | Itraconazole | Clotrimazole |
| Most Serious Side Effect | Potential for liver damage, heart related issues, severe skin reactions, and vision problems. | Severe allergic reactions including hives; difficulty breathing; swelling of your face, lips, tongue, or throat. |
| Severe Drug Interactions | Can interact negatively with certain medications, requiring a period to clear from the system before starting treatment. | Minimal due to its topical application, but always consult with a healthcare provider. |
| Typical Dose | 100-400 mg/day, with 200 mg/day being effective for most fungal infections. | 1% to 2% cream, lotion or lozenge form applied two to three times per day. |
What is Itraconazole?
Itraconazole (the generic name for Sporanox) is an antifungal medication that belongs to the class of drugs known as azoles. It was first approved by the FDA in 1992. Itraconazole works by preventing fungi from producing a substance called ergosterol, which is vital for their cell membranes. Therefore, it's highly effective in treating a variety of fungal infections but should be used with caution due to potential side effects and drug interactions.
On the other hand, Clotrimazole (brand names include Lotrimin and Mycelex) also belongs to the group of medicines called antifungals. However, unlike Itraconazole which is taken orally or intravenously and works systemically, clotrimazole usually comes in topical forms such as creams or lozenges applied directly where the infection exists.
While both medications are aimed at fighting fungal infections, they have different scopes and methods of administration due to their unique chemical structures and mechanisms of action.
What conditions is Itraconazole approved to treat?
Itraconazole is approved for the treatment of a variety of fungal infections, including:
- Systemic fungal infections (such as blastomycosis, histoplasmosis)
- Onychomycosis of the toenail or fingernail caused by dermatophytes
- Oral thrush in immunocompromised patients
- Infections caused by Candida species.
On the other hand, clotrimazole treats more localized conditions like:
- Tinea pedis (athlete's foot)
- Tinea cruris (jock itch)
- Tinea corporis (ringworm)
Both medications are designed to combat different types and severities of fungal infection.
How does Itraconazole help with these illnesses?
Itraconazole works to treat fungal infections by inhibiting the synthesis of ergosterol, a key component in the cell membranes of fungi. It does this by interfering with the enzyme cytochrome P450 14α-demethylase, which is necessary for converting lanosterol into ergosterol. Without sufficient levels of ergosterol, holes appear in the cell membrane leading to leakage of cellular contents and ultimately death of the fungus. Ergosterol plays an important role in maintaining the structure and function of fungal cell membranes similar to how cholesterol functions within human cells. By disrupting its production, itraconazole can limit growth and replication of various types of fungi helping patients manage their condition.
On a similar note but different mechanism, Clotrimazole also combats fungal infections though primarily used topically for skin-based conditions such as ringworm or athlete's foot. Clotrimazole impairs another enzyme crucial for ergosterol synthesis called Ergesterol Synthase thus compromising fungal cell wall integrity leading to collapse and death thereby alleviating symptoms associated with these conditions.
What is Clotrimazole?
Clotrimazole, often sold under the brand name Canesten, is an antifungal medication. It works by inhibiting the growth of fungus by interfering with their cell membrane formation. Clotrimazole was first approved by the FDA in 1975 and became available as an over-the-counter medication in 1992. Unlike itraconazole, which is a systemic antifungal drug taken orally or intravenously to treat a wide range of fungal infections throughout the body, clotrimazole is typically used topically for localized skin and mucosal surface infections such as athlete's foot, jock itch and yeast infections. Its side effect profile is also different from that of systemic drugs like itraconazole; clotrimazole does not usually cause systemic side effects because its action largely remains at the site of application. The local treatment approach can be beneficial particularly in patients who cannot tolerate oral medications or those who have mild to moderate localized fungal infections.
What conditions is Clotrimazole approved to treat?
Clotrimazole is an antifungal medication that has been endorsed for the treatment of a variety of fungal infections including:
- Athlete's foot (tinea pedis)
- Jock itch (tinea cruris)
- Ringworm (tinea corporis)
It's also used to treat yeast infections of the skin, mouth, and vagina. Clotrimazole works by stopping the growth of fungus on your skin.
How does Clotrimazole help with these illnesses?
Clotrimazole is an antifungal medication that combats infections caused by fungus. It works by inhibiting the growth of fungi and yeast by interfering with their cell membranes. This disruption in structure leads to a change in permeability, causing essential constituents of the fungal cells to leak out, which ultimately prevents the fungi from proliferating and causes them to die off.
Much like itraconazole, clotrimazole is applied topically for localised skin infections such as ringworm or athlete's foot but has a broader scope due to its less systemic nature compared to itraconazole. Clotrimazole can also be used for vaginal yeast infections as well as oral thrush, making it quite versatile. It is often chosen when treating superficial mycoses (fungal diseases affecting skin or mucous membrane), whereas systemic antifungals like itraconazole are preferred when dealing with more severe internal fungal infections.
How effective are both Itraconazole and Clotrimazole?
Both itraconazole and clotrimazole have well-established histories of effectively treating fungal infections. They were both approved by the FDA in the 1970s, initially for different types of fungal infections but now are used interchangeably for various conditions. Both drugs function by inhibiting ergosterol synthesis, a critical component of the fungal cell membrane.
In a double-blind clinical trial conducted in 2001 which compared these two agents head-to-head for treating tinea corporis or tinea cruris (commonly known as ringworm), both medications demonstrated comparable efficacy and safety profiles. No significant differences were observed between patients receiving itraconazole and those receiving clotrimazole across multiple metrics measuring treatment success.
A review published in 2015 on meta-analysis reports showed that clotrimazole is effective from the first week of treatment, has fewer side effects compared to other antifungal treatments like ketoconazole, and that it's well-tolerated even among pediatrics and geriatric populations. This research stated that clotrimazole is one of the most widely prescribed topical antifungal worldwide due to its broad-spectrum activity against dermatophytes.
A more recent study published in 2020 indicated that oral itraconazole seems to be more effective than placebo at treating toenail fungus (onychomycosis). However, while topical forms are generally safe with minimal systemic absorption leading to lesser side effects, oral administration can lead to liver damage if taken over long periods or at high doses. Therefore oral use usually requires monitoring liver enzymes during therapy particularly when co-prescribed alongside other hepatotoxic drugs.
Related trials for itraconazole and clotrimazole
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Itraconazole typically prescribed?
Oral dosages of Itraconazole typically range from 100-400 mg/day depending on the specific condition being treated, but studies have indicated that 200 mg/day is usually effective for treating fungal infections in most people. Children's dosage should be determined by a healthcare provider. In either population, if there is no response after a few weeks, your doctor may adjust the dosage accordingly. The maximum daily dosage of Itraconazole varies based on the individual and their specific health situation but should not exceed 400 mg/day unless specifically directed by a healthcare professional.
At what dose is Clotrimazole typically prescribed?
Clotrimazole treatment typically begins with local application of the cream, lotion or lozenge form at a concentration of 1% to 2%. This can be applied two to three times per day, depending on the severity and location of the fungal infection. The duration of use also varies based on type and extent of infection but generally lasts for a few weeks. If there is no response to clotrimazole after this period, it may be necessary to reconsider your treatment options. For more severe cases, usage might need to be extended beyond several weeks and should always proceed under medical guidance.
What are the most common side effects for Itraconazole?
Common side effects of Itraconazole may include:
- Nausea, vomiting or upset stomach
- Diarrhea or constipation
- Headache, dizziness
- Itching and skin rash
- Changes in taste sensation
- Hair loss (less common)
Whereas Clotrimazole typically has fewer systemic side effects as it is often applied topically. However, some people might experience:
- Mild burning or stinging at the application site
- Redness, swelling or peeling of the treated skin area
Are there any potential serious side effects for Itraconazole?
While itraconazole and clotrimazole are both antifungal medications, they can sometimes cause different side effects. For instance, while using itraconazole:
- Some individuals may experience allergic reactions which could manifest as hives; difficulty in breathing or swallowing; swelling of the face, lips, tongue or throat.
- In rare cases severe skin reactions like a red or purple skin rash that spreads especially in the face or upper body causing blistering and peeling.
- Vision problems such as blurred vision, double vision or other vision changes might be experienced.
- Heart related issues such as fast/pounding heartbeats; chest pain spreading to your jaw or shoulder; sudden numbness/weakness on one side of your body; slurred speech could occur.
- Signs of liver problem--nausea, vomiting, flu-like symptoms (fever), dark urine and jaundice (yellowing of the skin) might also surface.
On the other hand with clotrimazole:
- Allergic reaction: itching/swelling (especially of the face/tongue/throat); severe dizziness; trouble breathing
- Irritation where this drug is used
- Abdominal cramps
It's important to remember that these are potential risks and most people do not experience them. If you have any worries about taking either medication then consult with your healthcare provider who will be able to give advice based on your specific situation.
What are the most common side effects for Clotrimazole?
Clotrimazole, a commonly used antifungal medication, can trigger certain side effects such as:
- Irritation or burning sensation at the site of application
- Swelling or redness on the skin where applied
- Stomach upset
- Vomiting
- An unusual increase in urination
- Mild rash On rare occasions, it might cause more serious symptoms like blistering, peeling and severe irritation on the area of application. If you experience any signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat while using clotrimazole - seek medical help immediately. As always with medications though these side effects are not experienced by everyone and many people use Clotrimazole without issue.
Are there any potential serious side effects for Clotrimazole?
Clotrimazole is generally well-tolerated, but it can occasionally cause side effects. When using clotrimazole, be aware of the potential for:
- Skin irritation or burning sensation at the site of application
- Swelling and redness in areas where the medication has been applied
- Unusual skin changes, including blistering or peeling skin
- Signs of a severe allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat
If any discomfort continues after applying clotrimazole cream or if you notice any other symptoms that concern you such as rapid heartbeats or unusual behavioural changes (although these are rare), seek medical advice immediately.
Contraindications for Itraconazole and Clotrimazole?
Both Itraconazole and Clotrimazole, much like other antifungal medications, may lead to adverse side effects in some people. If you notice your symptoms worsening, or an increase in allergic reactions such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing after taking these drugs, please seek immediate medical attention.
Neither Itraconazole nor Clotrimazole should be taken if you are using certain types of medication that could interact with them negatively. Always inform your doctor about any medications you are currently taking; certain medicines can interfere with how these antifungals work and might require a period to clear from the system before starting treatment with either Itraconazole or Clotrimazole. These include drugs used for heart disease like quinidine and dofetilide among others.
How much do Itraconazole and Clotrimazole cost?
For the brand name versions of these antifungal medications:
- The price for 30 capsules of Sporanox (Itraconazole, 100 mg) averages around $600, which works out to about $20/day.
- A tube (15 g) of Lotrimin (Clotrimazole, 1%) averages about $10–$15; if used twice daily as directed, it could last up to two weeks. This means you would spend approximately $0.70–$1 a day.
Thus, if your treatment requires oral medication like Itraconazole rather than a topical cream such as Clotrimazole, be aware that the cost per day will be significantly higher. However, remember that the type and severity of fungal infection dictate which drug is most suitable for your situation.
As far as generic versions are concerned:
- Generic Itraconazole costs between $80 and $250 for 30 capsules depending on your location and pharmacy while working out at roughly between $2.5 to nearly over $8 per day.
- Generic Clotrimazole is available in tubes similar in size to its branded counterpart with prices ranging from just under a dollar up to about five dollars per tube making it quite affordable even when compared against its own branded version.
Popularity of Itraconazole and Clotrimazole
Clotrimazole, a common antifungal treatment available in generic form and under various brand names, was estimated to have been prescribed to about 2.5 million people in the US in 2020. It is frequently used for topical applications such as treating athlete's foot, jock itch, or ringworm infections. Clotrimazole accounted for roughly 10% of all topical antifungal prescriptions in the US.
Itraconazole, including brand versions such as Sporanox, was prescribed to approximately 1 million people in the USA during the same period. In terms of systemic antifungals (those taken orally or via injection), itraconazole accounts for close to 7%. This drug is typically used when a more aggressive or systemic fungal infection requires treatment beyond what can be achieved with a topical medication alone. The prevalence of itraconazole has been steady over recent years while clotrimazole has seen slight increases likely due its versatility and affordability.
Conclusion
Both itraconazole and clotrimazole are used in the treatment of fungal infections, with a long-standing record of efficacy and safety. They work differently: itraconazole is a systemic antifungal that inhibits the synthesis of ergosterol, an essential component of the fungal cell membrane; clotrimazole, on the other hand, is primarily applied topically to treat skin and mucous membrane infections.
Itraconazole can be used for a wider range of conditions including systemic mycoses such as blastomycosis or histoplasmosis. Clotrimazole would usually be considered for localized skin or yeast infections (e.g., thrush), or in patients who cannot tolerate oral medications due to side effects like stomach upset.
Both drugs are available in generic form which presents cost savings for those paying out-of-pocket. While both drugs generally have good tolerability profiles, there may still be side effects present during treatment - these include nausea or diarrhea for itraconazole; burning sensation at application site for clotrimazole.
The choice between these two will largely depend upon the specific type and location of infection along with patient's medical history among other factors. Always consult your healthcare provider before starting any medication regimen.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Zaias, N. (1977, March 1). Superficial Mycoses. Archives of Dermatology. American Medical Association (AMA).http://doi.org/10.1001/archderm.1977.01640030053007
- Sawyer, P. R., Brogden, R. N., Pinder, R. M., Speight, T. M., & Avery, G. S. (1975). Clotrimazole. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197509060-00003
- Kirkpatrick, C. H., & Alling, D. W. (1978, November 30). Treatment of Chronic Oral Candidiasis with Clotrimazole Troches. New England Journal of Medicine. Massachusetts Medical Society.http://doi.org/10.1056/nejm197811302992201
- Croxtall, J. D., & Plosker, G. L. (2009). Sertaconazole. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200969030-00009
- Caputo, R. (2003, December). Itraconazole (Sporanox®) in superficial and systemic fungal infections. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/14787210.1.4.531
- Vanden Bossche, H., Marichal, P., Le Jeune, L., Coene, M. C., Gorrens, J., & Cools, W. (1993, October). Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. American Society for Microbiology.http://doi.org/10.1128/aac.37.10.2101
- Crowley, P. D., & Gallagher, H. C. (2014, June 30). Clotrimazole as a pharmaceutical: past, present and future. Journal of Applied Microbiology. Oxford University Press (OUP).http://doi.org/10.1111/jam.12554
- Hardin, T. C., Graybill, J. R., Fetchick, R., Woestenborghs, R., Rinaldi, M. G., & Kuhn, J. G. (1988, September). Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrobial Agents and Chemotherapy. American Society for Microbiology.http://doi.org/10.1128/aac.32.9.1310
- Linpiyawan, R., Jittreprasert, K., & Sivayathorn, A. (2000, November). Clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients. International Journal of Dermatology. Wiley.http://doi.org/10.1046/j.1365-4362.2000.00087.x
- Wolfson, N., Riley, J., Samuels, B., & Singh, J. M. (1981, January). Clinical Toxicology of Clotrimazole When Administered Vaginally. Clinical Toxicology. Informa UK Limited.http://doi.org/10.3109/15563658108990012
- Bolla, P. K., Meraz, C. A., Rodriguez, V. A., Deaguero, I., Singh, M., Yellepeddi, V. K., & Renukuntla, J. (2019, August 29). Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies. Molecules. MDPI AG.http://doi.org/10.3390/molecules24173139
- Tobin, J. M., Loo, P., & Granger, S. E. (1992, February 1). Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Sexually Transmitted Infections. BMJ.http://doi.org/10.1136/sti.68.1.36